Tag: Canntab Therapeutics Limited

May 21, 2019

Canntab Receives Cultivation Licence for Industrial Hemp

Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQX:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading innovator in hard pill oral dose therapeutic cannabinoid...
December 5, 2018

FSD Pharma Congratulates Partner Canntab on Launch of Research Partnership with Leading Orthopaedic Surgeon Dr. Don Garbuz, M.D.

- FSD Pharma to work with Canntab to create tablets for the clinical research study at its facility in Cobourg,...
September 25, 2018

FSD Pharma Receives First Delivery of Canntab Equipment with a Capacity to Manufacture Approx. 1,500,000 Tablets Per Day

FSD Pharma Inc, (CSE:HUGE) (OTC :FSDDF ) (FRA: 0K9) ("FSD Pharma" or the "Company), which, through its wholly-owned subsidiary FV Pharma...
September 18, 2018

Emblem and Canntab to Commence Clinical Testing of 12-Hour Extended Release Cannabis Tablets

Emblem (TSXV:EMC,OTCQX:EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis under...